However it seems that homozygous loss of the Cdkn2a gene is sufficient for the development of asbestos-induced MM in the absence of other common MM driver mutations at the genetic and transcriptomic level in this model. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.